The 7th International Congress of Genitourinary Oncology will be held on January 31 and February 1, 2025 in Fez. Organized by the Chifae association for cancer prevention and research, in partnership with the Gustave Roussy Institute (IGR) and other international institutions, this event will bring together national and international experts to discuss recent advances in cancer treatment. in charge of urogenital cancers.
“This 2025 edition will thus offer an exceptional platform to discuss recent scientific advances, new therapeutic approaches, new operating and radiotherapy techniques as well as innovative technologies in cancer prevention and research,” specify the organizers in a press release. .
An opening to Africa, a first in the history of the congress
For the first time, this scientific meeting includes a session dedicated to onco-urology in Africa. “Devoting a large part of the work to onco-urology in Africa, the event will see the participation of representatives from several African countries. And for the first time in Morocco and the continent, this 7th Congress will be marked by the creation of an African onco-urology network,” underlines the press release. The main objective of this initiative will be to pool the efforts of all practitioners in Africa and to join forces in this fight against genitourinary cancer. A decisive step in the fight against urogenital cancer. According to Professor Nawfel Mellas, head of the medical oncology department at Hassan II University Hospital in Fez and president of the Chifae association for cancer prevention and research, the organization of this 7th edition constitutes a key step in the fight against urogenital cancers. “We are honored to welcome world-renowned oncologists and specialists to discuss recent scientific advances in this field. Advances that will fundamentally redefine our approach to the treatment of these cancers. This 7th Congress also represents a privileged moment of exchange, an opportunity for dialogue and continued commitment to raise awareness of the care of cancer patients,” explains Professor Mellas.
-A varied and diverse scientific program
Like the previous ones, this edition will highlight and strengthen international partnerships with world-class organizations such as the Gustave Roussy Institute (IGR), the International Society for Rare Urinogenital Cancers (Global Society Of Rare GU Tumors (GSRGT) and the International Bladder Cancer Group (IBCG). A strategic cooperation which will further enrich scientific exchanges while diversifying expertise.
Co-chaired by Professor Nawfel Mellas and Professor Karim Fizazi, renowned world expert in genitourinary cancers, this edition offers a varied and diversified scientific program. On the menu, specific medical workshops dedicated to prostate, bladder and kidney cancers. Also on the program are workshops in urology, onco-pathology and radiotherapy led by international and national experts. These scientific sessions, led by renowned oncology experts, will offer a summary of recent research while sharing the latest advances in innovative techniques and treatments, namely targeted molecular therapies, perioperative treatments, new techniques. surgical and other therapeutic algorithms of 2025. “Beyond the scientific scope of the event and its international influence, this 7th Congress marks the renewed commitment of the Chifae association in the fight against cancer and for a quality continuing medical education. Reaffirming its leadership role in promoting continuing education in oncology, the association works tirelessly to broaden the perspectives of practitioners in this field on an international scale. Faithful to its commitments, Chifae actively contributes, via the congress and its various actions, to the dissemination of knowledge, but also of good practices for an effective fight against cancer,” concludes the press release.
